Annual Operating Margin
32.15%
NaN%
December 31, 2023
Summary
- As of February 7, 2025, CTNM annual operating profit margin is 32.15%
- CTNM annual operating margin is now at all-time high.
Performance
CTNM Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Margin
N/A
September 30, 2024
Summary
- CTNM quarterly operating profit margin is not available.
Performance
CTNM Quarterly Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Operating Margin Formula
Operating Profit Margin = Operating Profit
Revenue ✕ 100%
Revenue ✕ 100%
CTNM Operating Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
CTNM Operating Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | ||
| 5 y | 5-year | at high | at low | ||
| alltime | all time | at high | at low |
Contineum Therapeutics Class A Operating Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | 32.15% | - |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | 77.87% |
FAQ
- What is Contineum Therapeutics Class A annual operating profit margin?
- What is the all time high annual operating margin for Contineum Therapeutics Class A?
- What is the all time high quarterly operating margin for Contineum Therapeutics Class A?
What is Contineum Therapeutics Class A annual operating profit margin?
The current annual operating margin of CTNM is 32.15%
What is the all time high annual operating margin for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high annual operating profit margin is 32.15%
What is the all time high quarterly operating margin for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high quarterly operating profit margin is 77.87%